Kenya vs SEAR: Estimated antiretroviral therapy coverage among people living with HIV
Kenya
91.0%
in 2025
SEAR
22.0%
in 2025
Kenya rank
15th
SEAR rank
12th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Kenya
- SEAR
How they compare
Kenya currently reports 91.0% against 22.0% in SEAR, a difference of 69.0%.
That makes Kenya's figure about 4.1 times SEAR's.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was SEAR ahead.
Kenya ranks 15th and SEAR ranks 12th of 143 countries.
Kenya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kenya | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 2.2% | 4.5% | Kenya |
| 2010s | 54.2% | 12.3% | 41.9% | Kenya |
| 2020s | 85.0% | 20.3% | 64.7% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Kenya or SEAR?
- Kenya, at 91.0% against 22.0% in SEAR as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Kenya and SEAR?
- 69.0%, with Kenya ahead.
- How many years of comparable data are there for Kenya and SEAR?
- 26 years are reported by both, from 2000 to 2025.
- How do Kenya and SEAR rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Kenya ranks 15th and SEAR ranks 12th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.